Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer Ying FanRui SunJie Ma Original Article – Clinical Oncology 18 May 2022 Pages: 1667 - 1677
The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer Yong WangNingning LuoShuanghu Yuan Original Article – Clinical Oncology 18 May 2022 Pages: 1679 - 1690
Machine learning for optimized individual survival prediction in resectable upper gastrointestinal cancer Jin-On JungNerma CrnovrsaninThomas Schmidt Original Article – Clinical Oncology Open access 26 May 2022 Pages: 1691 - 1702
Quality assurance and improvement in oncology using guideline-derived quality indicators – results of gynaecological cancer centres certified by the German cancer society (DKG) E. GriesshammerS. WesselmannJ. Sehouli Original Article – Clinical Oncology Open access 03 June 2022 Pages: 1703 - 1715
Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma Monika ScheerErika HallmenCooperative Weichteilsarkom Studiengruppe [CWS] Original Article – Clinical Oncology Open access 10 June 2022 Pages: 1717 - 1731
Awareness and use of psychosocial care among cancer patients and their relatives—a comparison of people with and without a migration background in Germany Susanne SingerNicola RiccettiKerstin Hermes-Moll Original Article – Clinical Oncology Open access 11 June 2022 Pages: 1733 - 1745
Correlation of PD-L1 expression on tumour cells between diagnostic biopsies and surgical specimens of lung cancer in real life with respect to biopsy techniques and neoadjuvant treatment D. GompelmannK. SinnM. A. Hoda Original Article – Clinical Oncology Open access 16 June 2022 Pages: 1747 - 1754
Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy J. Nicholas BodorJessica R. BaumanJoseph Treat Original Article – Clinical Oncology 16 June 2022 Pages: 1755 - 1763
Continued adjuvant FOLFIRINOX for BRPC or LAPC after neoadjuvant FOLFIRINOX Jaewoo ParkHae Young KimJaihwan Kim Original Article – Clinical Oncology 20 June 2022 Pages: 1765 - 1775
Is adjacent lobe invasion an T category upgrade factor for resected non-small cell lung cancer ≤ 5 cm? Jing-Sheng CaiQian-Yi LinXiao-Meng Dou Original Article – Clinical Oncology 21 June 2022 Pages: 1777 - 1784
Homeopathy effects in patients during oncological treatment: a systematic review Anna WagenknechtJennifer DörflerJutta Huebner Original Article – Clinical Oncology Open access 22 June 2022 Pages: 1785 - 1810
Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis Laurelle van TilburgSteffi E. M. van de VenArjun D. Koch Original Article – Clinical Oncology Open access 23 June 2022 Pages: 1811 - 1823
Programmed cell death 1 pathway inhibitors improve the overall survival of small cell lung cancer patients with brain metastases JiaYu ChangXuQuan JingYan Zhang Original Article – Clinical Oncology Open access 23 June 2022 Pages: 1825 - 1833
Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients Andrea De GiglioChiara DeianaAlessandro Di Federico Original Article – Clinical Oncology Open access 24 June 2022 Pages: 1835 - 1847
Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter? Christian MöhringAliki TimotheouMaria A. Gonzalez-Carmona Original Article – Clinical Oncology 28 June 2022 Pages: 1849 - 1862
Cannabinoid consumption among cancer patients receiving systemic anti-cancer treatment in the Netherlands Yrina OelenSven RevenbergLiselot Valkenburg-van Iersel Original Article – Clinical Oncology Open access 02 July 2022 Pages: 1863 - 1872
Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization Wenzhe FanBowen ZhuJiaping Li Original Article – Clinical Oncology 05 July 2022 Pages: 1873 - 1882
Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma Gwladys ClaustreCoralie BoulangerVéronique Graff Original Article – Clinical Oncology 05 July 2022 Pages: 1883 - 1893
Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms Florian BöschAnnelore Altendorf-HofmannThomas Knösel Original Article – Clinical Oncology Open access 07 July 2022 Pages: 1895 - 1903
Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board Kathrin HeinrichLisa Miller-PhillipsC. Benedikt Westphalen Original Article – Clinical Oncology Open access 07 July 2022 Pages: 1905 - 1915
Triple therapy in biliary tract cancers: GemOX plus immune checkpoint inhibitor in combination with lenvatinib or NGS-guided targeted therapy Xiang DongZewu ZhangWei Zhang Original Article – Clinical Oncology 08 July 2022 Pages: 1917 - 1927
Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis Antje MeviusFlorian KarlThomas Wilke Original Article – Clinical Oncology Open access 16 July 2022 Pages: 1929 - 1939
Powering single-cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients Emmanuel AcheampongMichael MoriciAaron B. Beasley Original Article – Clinical Oncology Open access 28 July 2022 Pages: 1941 - 1950
Long-term oncologic outcomes of robot-assisted versus open radical prostatectomy for prostate cancer with seminal vesicle invasion: a multi-institutional study with a minimum 5-year follow-up Jungyo SuhIn Gab JeongHanjong Ahn Original Article – Clinical Oncology 09 August 2022 Pages: 1951 - 1960
Osteosarcoma pre-diagnosed as another tumor: a report from the Cooperative Osteosarcoma Study Group (COSS) Stefanie Hecker-NoltingDaniel BaumhoerStefan S. Bielack Original Article – Clinical Oncology 18 August 2022 Pages: 1961 - 1967
Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer Jingchao LiuWei ZhangJianye Wang OriginalPaper 22 June 2022 Pages: 1969 - 1983
Attitude towards and perception of individual safety after SARS-CoV-2 vaccination among German cancer patients Oliver OverheuSimon LendowskiAnke Reinacher-Schick OriginalPaper Open access 22 June 2022 Pages: 1985 - 1992
Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis Zi-Niu DingGuang-Xiao MengTao Li ReviewPaper 29 June 2022 Pages: 1993 - 2008
The protective effect of aspirin-induced temporary threshold shift in an animal model of cisplatin-related ototoxicity Sharon TzelnickAviram MizrachiOhad Hilly OriginalPaper 01 July 2022 Pages: 2009 - 2016
The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis Yanxia HeYan GaoHuiqiang Huang OriginalPaper 09 July 2022 Pages: 2017 - 2027
Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations Xiaoli ZhuoHonglin GuoGuobin Fu OriginalPaper 13 July 2022 Pages: 2029 - 2039
LPAR2-mediated action promotes human renal cell carcinoma via MAPK/NF-κB signaling to regulate cytokine network Yuewu WangZhimin QiAlatangaole Damirin OriginalPaper 20 July 2022 Pages: 2041 - 2055
Phytotherapy known and applied by head-neck cancer patients and medical students to treat oral discomfort in Germany: an observational study Maria-Louisa RitschelJutta HübnerJudith Büntzel OriginalPaper Open access 23 July 2022 Pages: 2057 - 2070
Immunotherapy for the treatment of advanced nasopharyngeal carcinoma: a promising new era Shaoli WangSiying ChenYan Liu ReviewPaper 25 July 2022 Pages: 2071 - 2079
Prognostic utility of SOX2, STAT3, and CD44high/CD24low expression in penile cancer Felipe Dubourcq de BarrosLeuridan Cavalcante TorresGustavo Cardoso Guimarães OriginalPaper 01 August 2022 Pages: 2081 - 2094
Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention Adem OzleyenYakup Berkay YilmazTugba Boyunegmez Tumer Review 25 July 2022 Pages: 2095 - 2113
Metabolic targeting of malignant tumors: a need for systemic approach Aggelos T. Margetis Review 04 August 2022 Pages: 2115 - 2138
The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive review Jennifer R. LandesStephen A. MooreStephen K. Tyring Review 08 August 2022 Pages: 2139 - 2155
The benefits of vitamin A as a complementary treatment for oncology patients: a systematic review Theresa RetzlaffJennifer DörflerJutta Hübner Review 16 August 2022 Pages: 2157 - 2177
PD-1/PD-L1 inhibitors in treatment-naïve, advanced non-small cell lung cancer patients with < 1% PD-L1 expression: a meta-analysis of randomized controlled trials Durgesh WankhedePaul HofmanSandeep Grover Review 19 August 2022 Pages: 2179 - 2189
Neutrophil extracellular traps facilitate cancer metastasis: cellular mechanisms and therapeutic strategies Wenxing HuSerene M. L. LeeHanno Nieß Review Open access 01 September 2022 Pages: 2191 - 2210
The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review Sajad Najafi Review 02 September 2022 Pages: 2211 - 2234
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival Abdul MiahGabriel TinocoDwight H. Owen Review 07 September 2022 Pages: 2235 - 2242
Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer Lulu ZhangBo ZhangSiji Nian Review 15 September 2022 Pages: 2243 - 2258
Metabolic changes during prostate cancer development and progression Alicia-Marie K. BeierMartin PuhrHolger H. H. Erb Review Open access 23 September 2022 Pages: 2259 - 2270